by Paulo Coelho
with a vision for building a world class contract manufacturing organization. This vision grew from years of frustration with unresponsive CMOs, rejected batches, regulatory issues and an overall lack of capacity to reliably manufacture drug product.
Initial investment was provided by a core group of local healthcare providers and business owners. A team of industry experts was assembled, and work began on designing both the facility and the advanced digital manufacturing systems. Selkirk completed facility design and broke ground in September 2020.
With construction finished in the fall of 2022, a team of 80 employees began facility and equipment qualification and validation activities. Technical transfers for commercial and clinical trial projects will begin in Q2 of 2023. GMP Operations will be fully qualified by the end of third quarter 2023 with client batches starting in fourth quarter 2023.
Selkirk employees all have an ownership stake in the company. Our experienced team has an average of over 20 years experience. And we have multi-disciplinary teams to support project transfer to Selkirk.